Metabolism and accumulation of the lipophilic deoxynucleoside analogs elacytarabine and CP-4126-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Metabolism and accumulation of the lipophilic deoxynucleoside analogs elacytarabine and CP-4126

Published:2011-10-15 Issue:5 Volume:30 Page:1908-1916
ISSN:0167-6997
Container-title:Investigational New Drugs
language:en
Short-container-title:Invest New Drugs

Author:

Adema Auke D.,Smid Kees,Losekoot Nienke,Honeywell Richard J.,Verheul Henk M.,Myhren Finn,Sandvold Marit L.,Peters Godefridus J.

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),Pharmacology,Oncology

Link

http://www.springerlink.com/index/pdf/10.1007/s10637-011-9756-8

Reference29 articles.

1. Plunkett W, Gandhi V (1993) Cellular pharmacodynamics of anticancer drugs. Semin Oncol 20:50–63

2. Rustum YM, Raymakers RA (1992) 1-Beta-arabinofuranosylcytosine in therapy of leukemia: preclinical and clinical overview. Pharmacol Ther 56:307–321

3. Ramalingam S, Belani C (2008) Systemic chemotherapy for advanced non-small cell lung cancer: recent advances and future directions. Oncologist 13(Suppl 1):5–13

4. Heinemann V (2002) Gemcitabine in the treatment of advanced pancreatic cancer: a comparative analysis of randomized trials. Semin Oncol 29:9–16

5. Hussain SA, James ND (2003) The systemic treatment of advanced and metastatic bladder cancer. Lancet Oncol 4:489–497

Cited by 44 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Effects of nucleoside analogues, lipophilic prodrugs and elaidic acids on core signaling pathways in cancer cells;Nucleosides, Nucleotides & Nucleic Acids;2024-04-15

2. Self-assembled lipid–prodrug nanoparticles;Nature Reviews Bioengineering;2023-06-28

3. Tumor microenvironment stimuli-responsive lipid-drug conjugates for cancer treatment;International Journal of Pharmaceutics;2023-05

4. Advancement in transporter-oriented nanoplatforms for cancer therapy;Journal of Drug Targeting;2023-04-05

5. Design, Synthesis, and Anti-Cancer Evaluation of Novel Cyclic Phosphate Prodrug of Gemcitabine;Journal of Medicinal Chemistry;2023-03-03

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3